Guangdong Taienkang Pharmaceutical Co., Ltd. (301263.SZ) — Stock Score Summary

Guangdong Taienkang Pharmaceutical Co., Ltd. (301263.SZ) has a MoatMap StockRank of 5/100 based on Quality (47/100), Value (7/100), and Momentum (28/100) factor scores. The current signal is STRONG SELL. Guangdong Taienkang Pharmaceutical lacks the scale, global regulatory validation, and high-ROIC profile required to benefit from the CDMO pricing power cycle. It remains a localized player without a clear asymmetric macro tailwind.

Guangdong Taienkang Pharmaceutical Co., Ltd. operates a diversified pharmaceutical business encompassing drug R&D, manufacturing, and commercial agency services. The company is well-known for its strong sales network and exclusive distribution rights for prominent imported OTC and prescription drugs in China. Its competitive advantage lies in its highly efficient commercialization platform and a growing pipeline of self-developed generic and innovative drugs.

Key Financial Metrics

Price$2.76
Market Cap$1.6B
P/E (TTM)326.83
Price/Book5.87
Return on Equity0.4%
Return on Invested Capital0.2%
Debt/Equity20.34
Gross Margin53.3%
Operating Margin18.0%
Revenue Growth2.6%
Dividend Yield0.2%
Free Cash Flow$179K

Guangdong Taienkang Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Guangdong Taienkang Pharmaceutical Co., Ltd.’s (301263.SZ) StockRank?
MoatMap’s StockRank for Guangdong Taienkang Pharmaceutical Co., Ltd. (301263.SZ) is 5/100, with a Strong Sell signal. It is a composite of Quality (47), Value (7), and Momentum (28) factor ranks across MoatMap’s 19,000+ stock universe.
Does Guangdong Taienkang Pharmaceutical Co., Ltd. have an economic moat?
Guangdong Taienkang Pharmaceutical Co., Ltd. (301263.SZ) has a Quality factor score of 47/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Guangdong Taienkang Pharmaceutical Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Guangdong Taienkang Pharmaceutical Co., Ltd. (301263.SZ) is Strong Sell, based on a StockRank of 5/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Guangdong Taienkang Pharmaceutical Co., Ltd. in?
Guangdong Taienkang Pharmaceutical Co., Ltd. (301263.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).
Browse all ranked stocks301263.SZ deep dive reportAI ChampionsHow we score stocksSense-check another stock